Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Ordinary Shares Nominal value of NIS 0.0000769 per share
-
Shares outstanding
-
45.5M
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
2.57M
-
Shares change
-
-262K
-
Total reported value, excl. options
-
$2.17M
-
Value change
-
-$315K
-
Put/Call ratio
-
0
-
Number of buys
-
6
-
Number of sells
-
-3
-
Price
-
$0.84
Significant Holders of Entera Bio Ltd. - Ordinary Shares Nominal value of NIS 0.0000769 per share (ENTX) as of Q2 2023
14 filings reported holding ENTX - Entera Bio Ltd. - Ordinary Shares Nominal value of NIS 0.0000769 per share as of Q2 2023.
Entera Bio Ltd. - Ordinary Shares Nominal value of NIS 0.0000769 per share (ENTX) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.57M shares
of 45.5M outstanding shares and own 5.65% of the company stock.
Largest 10 shareholders include Knoll Capital Management, LLC (2.48M shares), HRT FINANCIAL LP (26.4K shares), GEODE CAPITAL MANAGEMENT, LLC (17.6K shares), RENAISSANCE TECHNOLOGIES LLC (16.1K shares), HighTower Advisors, LLC (11.8K shares), PNC Financial Services Group, Inc. (10K shares), MORGAN STANLEY (1.1K shares), UBS Group AG (1.06K shares), OSAIC HOLDINGS, INC. (750 shares), and CITADEL ADVISORS LLC (32 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.